ForDoz Pharma to manufacture LipoMedix’ oncology candidate Promitil

New Jersey-based ForDoz Pharma has signed an agreement with LipoMedix for manufacturing the latter’s lead compound - pegylated liposomal Promitil (PL-MLP) for a phase 2 ... Read More